Production (Stage)
Caribou Biosciences, Inc.
CRBU
$1.12
$0.010.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.99M | -35.49M | -34.68M | -37.70M | -41.23M |
| Total Depreciation and Amortization | 1.17M | 1.18M | 1.18M | 856.00K | 710.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.60M | 3.14M | 3.67M | 1.11M | 4.17M |
| Change in Net Operating Assets | -1.50M | -4.30M | -2.82M | 2.86M | -849.00K |
| Cash from Operations | -36.73M | -35.47M | -32.66M | -32.87M | -37.20M |
| Capital Expenditure | -1.04M | -518.00K | -673.00K | -2.24M | -1.45M |
| Sale of Property, Plant, and Equipment | -- | 13.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 50.42M | 16.44M | 27.19M | 23.44M | 24.40M |
| Cash from Investing | 49.38M | 15.93M | 26.52M | 21.20M | 22.96M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 468.00K | 3.86M | 244.00K | 132.00K | 12.49M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 468.00K | 3.86M | 244.00K | 132.00K | 12.49M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.12M | -15.68M | -5.90M | -11.53M | -1.76M |